Search

everythinglearnresearchcommunity

for

Search:↓

MENT could be a better option than testosterone for male hormone therapy and birth control because it works well at lower doses and has fewer side effects on the prostate.

The activity of a specific rat enzyme in the prostate and epididymis is highly dependent on the acidity level.

A vaccine may prevent benign prostatic hyperplasia (BPH).

Early balding, especially frontal, increases prostate cancer risk; more research needed.

% free PSA and urinary markers help better identify prostate cancer.

Hair loss gene linked to prostate issues.

Prostate cancer can progress even with low testosterone due to internal hormone production in the tumor.

Drinking a lot of alcohol increases the risk of prostate cancer and can worsen the condition.

Androgen deprivation therapy doesn't lower the risk of death from COVID-19 in prostate cancer patients.

Don't combine abiraterone and spironolactone for prostate cancer treatment as it may worsen the disease.

Men with vertex baldness may have a higher risk of developing prostate cancer, but more research is needed to confirm this.

Certain genetic variants in the androgen receptor are linked to higher PSA levels, potentially affecting prostate cancer screening outcomes.

Higher DHT in male baldness may protect against prostate cancer.

Finasteride for hair loss is safe and does not increase the risk of high-grade prostate cancer.

Berberine may reduce prostate enlargement by blocking inflammation.

Women with congenital adrenal hyperplasia showed no prostatic growth.

Men with male pattern baldness have a higher risk of aggressive prostate cancer and benign prostatic hyperplasia.

Baldness in men with prostate cancer is linked to higher levels of certain sex hormones, but chest hair density is not.

Cimicifuga racemosa extract may help prevent and treat prostate issues by inhibiting 5α-reductase.

Prostate size varies by ethnic group, age, residence, and blood glucose, but not by body measurements or fat.

PSA levels are higher in women with PCOS, but FAI is a more accurate marker for diagnosis.

2007 research improved understanding of prostate cancer risk, diagnosis, and treatment, but also showed the need for personalized treatment and further study on certain therapies' risks.

Male pattern baldness might have evolved to help protect against prostate cancer by increasing UV radiation on the scalp.

Older age is the main risk factor for hemorrhagic cystitis after stem cell transplants.

Tripterygium wilfordii multiglycoside effectively reduced prostate enlargement in rats without harmful effects.

Early hair loss may indicate future prostate issues.

New steroids were effective in blocking male hormone receptors in hamster prostates.

New BPH treatments have low sexual dysfunction risk but may not improve urinary symptoms as much as traditional surgery.

Dihydroartemisinin helps reduce prostate enlargement in rats by stopping the growth of prostate cells.

Prostate cancer patients need early psychological and sexual support during radiotherapy to improve their quality of life.